Back
Las Vegas Sands Corp. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
75
LVS
Las Vegas Sands Corp.
Last Price:
$66.18
Seasonality Move:
2.96%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$35.06
Seasonality Move:
-22.7%
Buy
75
Las Vegas Sands Corp. (LVS)
is a Buy
Is Las Vegas Sands Corp. a Buy, Sell or Hold?
-
The current Las Vegas Sands Corp. [LVS] share price is $66.20. The Score for LVS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
LVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LVS Stock Price Chart
What is Las Vegas Sands Corp.'s stock price today?
-
The Las Vegas Sands Corp. share price today is $66.20The current trend is moderately bearish and LVS is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $35.09The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
LVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 53.04 | Buy |
| Chaikin Money Flow: | -1216674 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.44 - 67.9) | Sell |
| Bollinger Bands (100): | (51.99 - 64.77) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.23 | Buy |
| Relative Strength Index (14 RSI): | 66.16 | Buy |
| Chaikin Money Flow: | -92149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.48 - 34.66) | Buy |
| Bollinger Bands (100): | (10.81 - 25.25) | Buy |
LVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.67 | Sell |
| 20-day SMA: | 66.87 | Sell |
| 50-day SMA: | 63.25 | Buy |
| 200-day SMA: | 50.22 | Buy |
| 8-day EMA: | 66.5 | Sell |
| 20-day EMA: | 66.25 | Sell |
| 50-day EMA: | 63.43 | Buy |
| 200-day EMA: | 54.3 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.85 | Buy |
| 20-day SMA: | 30.4 | Buy |
| 50-day SMA: | 22.87 | Buy |
| 200-day SMA: | 13.87 | Buy |
| 8-day EMA: | 35.03 | Buy |
| 20-day EMA: | 31.05 | Buy |
| 50-day EMA: | 24.98 | Buy |
| 200-day EMA: | 18 | Buy |
Las Vegas Sands Corp. Earnings Growth & LVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.28 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Las Vegas Sands Corp. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||